Recovery Trajectories After Total Knee Arthroplasty (NCT07595861) | Clinical Trial Compass
CompletedNot Applicable
Recovery Trajectories After Total Knee Arthroplasty
Turkey (Türkiye)40 participantsStarted 2025-04-01
Plain-language summary
This prospective cohort study aimed to compare recovery trajectories following cruciate-retaining (CR) and posterior-stabilized (PS) total knee arthroplasty (TKA) using rehabilitation-centered patient-reported outcome measures (PROMs). Forty patients undergoing primary unilateral TKA were evaluated preoperatively and at 3 and 6 months postoperatively. Outcomes included pain intensity, functional status, kinesiophobia, health-related quality of life, and joint awareness assessed using validated PROMs including the Visual Analog Scale (VAS), WOMAC, Tampa Scale for Kinesiophobia (TSK), SF-36, and Forgotten Joint Score-12 (FJS-12). The study investigated whether posterior cruciate ligament management influences early postoperative recovery trajectories after TKA.
Who can participate
Age range
50 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients scheduled for primary unilateral total knee arthroplasty (TKA).
* Ability to read and understand Turkish.
* Full orientation in person, place, and time.
* Voluntary participation with informed consent.
* Surgery performed at the same institution under standardized perioperative and postoperative care protocols.
Exclusion Criteria:
* Revision total knee arthroplasty.
* Presence of neuromuscular or neurological disorders affecting gait (e.g., stroke, Parkinson disease, myopathies).
* Cognitive impairment or diagnosed psychiatric disorders that may interfere with questionnaire completion or participation.
* Perioperative complications such as excessive bleeding, infection, prosthesis dislocation, or deep venous thrombosis.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Pain Intensity Assessed by Visual Analog Scale (VAS)
Timeframe: Baseline
2
Functional Status Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Timeframe: Baseline
3
Fear of Movement Assessed by Tampa Scale for Kinesiophobia (TSK)
Timeframe: Baseline
4
Health-Related Quality of Life Assessed by Short Form-36 (SF-36)
Timeframe: Baseline
5
Postoperative Joint Awareness Assessed by Forgotten Joint Score-12 (FJS-12)